Establishment of Immortalized Human Erythroid Progenitor Cell Lines Able to Produce Enucleated Red Blood Cells
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Transfusion of red blood cells (RBCs) is a standard and indispensable therapy in current clinical practice. In vitro production of RBCs offers a potential means to overcome a shortage of transfusable RBCs in some clinical situations and also to provide a source of cells free from possible infection or contamination by microorganisms. Thus, in vitro production of RBCs may become a standard procedure in the future. We previously reported the successful establishment of immortalized mouse erythroid progenitor cell lines that were able to produce mature RBCs very efficiently. Here, we have developed a reliable protocol for establishing immortalized human erythroid progenitor cell lines that are able to produce enucleated RBCs. These immortalized cell lines produce functional hemoglobin and express erythroid-specific markers, and these markers are upregulated following induction of differentiation in vitro. Most importantly, these immortalized cell lines all produce enucleated RBCs after induction of differentiation in vitro, although the efficiency of producing enucleated RBCs remains to be improved further. To the best of our knowledge, this is the first demonstration of the feasibility of using immortalized human erythroid progenitor cell lines as an ex vivo source for production of enucleated RBCs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






![Figure 7 Gene expression profiles of the established erythroid progenitor cell lines estimated by quantitative RT-PCR analysis. Analyzed genes are indicated. FL, results with cDNA derived from human fetal liver. Relative expression was evaluated compared to that of FL. CB, cord blood. CB 6, 10 and 16, results with cDNA derived from cultured erythroid cells, i.e., CD34-positive cells in CB were induced to differentiate into mature erythroid cells for 6, 10 and 16 days, respectively, using the previously reported method [4]. B and A, Before and 2 days after induction of differentiation of HiDEP and HUDEP cells.](https://figures.cochat.ai/paper-figures/2c1a4cd9be89480c8e81cf1b067b0b83/establishment-of-immortalized-human-erythroid-progenitor-cell-lines-able-to-figure-7.jpg)



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Furthermore, overexpression of CBL and CNN1 transgenes in a human erythroid progenitor model (HUDEP2 cells) individually and in combination also induced markers of erythroid differentiation (Fig. 3F–G and fig. S10C–D) (21).”
From Exploring genetic interaction manifolds constructed from rich single-cell phenotypes (2019) · cites this paper as [21]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.
Gossen, M., & Bujard, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5547 · Cited by 4,943 · cited 1×
“In order to test this possibility, we used a Tet-inducible expression system [18,19] to control expression of HPV16-E6/ E7 in iPS-derived hematopoietic progenitor cells and investigated whether such expression inhibited establishment of immortalized erythroid progenitor cell lines.”
MethodTranscriptional Activation by Tetracyclines in Mammalian Cells
Gossen, M., Freundlieb, S., Bender, G., Müller, G., Hillen, W., & Bujard, H. (1995) · Science · doi:10.1126/science.7792603 · Cited by 2,488 · cited 1×
“In order to test this possibility, we used a Tet-inducible expression system [18,19] to control expression of HPV16-E6/ E7 in iPS-derived hematopoietic progenitor cells and investigated whether such expression inhibited establishment of immortalized erythroid progenitor cell lines.”
MethodHuman Fetal Hemoglobin Expression Is Regulated by the Developmental Stage-Specific Repressor BCL11A
Sankaran, V. G., Menne, T. F., Xu, J., Akie, T. E., Lettre, G., Van Handel, B., Mikkola, H. K. A., Hirschhorn, J. N., Cantor, A. B., & Orkin, S. H. (2008) · Science · doi:10.1126/science.1165409 · Cited by 919
Absence of yolk sac hematopoiesis from mice with a targeted disruption of the scl gene.
Robb, L., Lyons, I., Li, R., Hartley, L., Köntgen, F., Harvey, R. P., Metcalf, D., & Begley, C. G. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.15.7075 · Cited by 577 · cited 1×
“TAL1 plays essential roles in early hematopoiesis [13] and differentiation of erythroid cells and megakaryocytes [14,15].”
BackgroundDevelopmental and species-divergent globin switching are driven by BCL11A
Sankaran, V. G., Xu, J., Ragoczy, T., Ippolito, G. C., Walkley, C. R., Maika, S. D., Fujiwara, Y., Ito, M., Groudine, M., Bender, M. A., et al. (2009) · Nature · doi:10.1038/nature08243 · Cited by 379 · cited 1×
“Of note, BCL11A, a repressor of c-globin expression [25] and critical mediator of globin switching [26], was abundantly detected only in the HUDEP-2 cell line in which b-globin was up-regulated after differentiation (Figure 7).”
BackgroundMikkola, H. K. A., Klintman, J., Yang, H., Hock, H., Schlaeger, T. M., Fujiwara, Y., & Orkin, S. H. (2003) · Nature · doi:10.1038/nature01345 · Cited by 371 · cited 1×
“TAL1 plays essential roles in early hematopoiesis [13] and differentiation of erythroid cells and megakaryocytes [14,15].”
BackgroundProof of principle for transfusion of in vitro–generated red blood cells
Giarratana, M.-C., Rouard, H., Dumont, A., Kiger, L., Safeukui, I., Le Pennec, P.-Y., François, S., Trugnan, G., Peyrard, T., Marie, T., et al. (2011) · Blood · doi:10.1182/blood-2011-06-362038 · Cited by 342
KARASAWA, S., ARAKI, T., NAGAI, T., MIZUNO, H., & MIYAWAKI, A. (2004) · Biochemical Journal · doi:10.1042/bj20040321 · Cited by 342 · cited 1×
“The CSIV-TRE-RfA-UbC-KT lentiviral vector plasmid (Figure S2) contains the humanized Kusabira-Orange 1 (hKO1) fluorescent protein gene [11] and the reverse tetracycline (Tet)-controlled transcriptional transactivator (TAKARA BIO) linked by the Thosea asigna virus 2A peptide sequence under the control of human ubiquiti…”
BackgroundBiologic properties and enucleation of red blood cells from human embryonic stem cells
Lu, S.-J., Feng, Q., Park, J. S., Vida, L., Lee, B.-S., Strausbauch, M., Wettstein, P. J., Honig, G. R., & Lanza, R. (2008) · Blood · doi:10.1182/blood-2008-05-157198 · Cited by 293 · cited 1×
“in vitro [1,2,3] from hematopoietic stem/progenitor cells [4,5], embryonic stem (ES) cells [6], or induced pluripotent stem (iPS) cells [7].”
BackgroundHuman erythroid cells produced ex vivo at large scale differentiate into red blood cells in vivo
Neildez-Nguyen, T. M. A., Wajcman, H., Marden, M. C., Bensidhoum, M., Moncollin, V., Giarratana, M.-C., Kobari, L., Thierry, D., & Douay, L. (2002) · Nature Biotechnology · doi:10.1038/nbt0502-467 · Cited by 267 · cited 1×
“in vitro [1,2,3] from hematopoietic stem/progenitor cells [4,5], embryonic stem (ES) cells [6], or induced pluripotent stem (iPS) cells [7].”
BackgroundLapillonne, H., Kobari, L., Mazurier, C., Tropel, P., Giarratana, M.-C., Zanella-Cleon, I., Kiger, L., Wattenhofer-Donze, M., Puccio, H., Hebert, N., et al. (2010) · Haematologica · doi:10.3324/haematol.2010.023556 · Cited by 242 · cited 1×
“in vitro [1,2,3] from hematopoietic stem/progenitor cells [4,5], embryonic stem (ES) cells [6], or induced pluripotent stem (iPS) cells [7].”
BackgroundHall, M. A., Curtis, D. J., Metcalf, D., Elefanty, A. G., Sourris, K., Robb, L., Göthert, J. R., Jane, S. M., & Begley, C. G. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0237324100 · Cited by 204 · cited 1×
“TAL1 plays essential roles in early hematopoiesis [13] and differentiation of erythroid cells and megakaryocytes [14,15].”
BackgroundMiharada, K., Hiroyama, T., Sudo, K., Nagasawa, T., & Nakamura, Y. (2006) · Nature Biotechnology · doi:10.1038/nbt1245 · Cited by 184 · cited 4×
“Second, as we have previously demonstrated, FBS can be replaced with human serum without compromising the production of abundant enucleated RBCs from hematopoietic stem/progenitor cells in cord blood [4].”
BackgroundMethodSelf-citationSox6 Directly Silences Epsilon Globin Expression in Definitive Erythropoiesis
Yi, Z., Cohen‐Barak, O., Hagiwara, N., Kingsley, P. D., Fuchs, D. A., Erickson, D. T., Epner, E. M., Palis, J., & Brilliant, M. H. (2005) · PLoS Genetics · doi:10.1371/journal.pgen.0020014 · Cited by 143 · cited 1×
“This was also the case for c-MYB and SOX6, which are markers of definitive erythroid cells [22,23,24].”
ResultHiroyama, T., Miharada, K., Sudo, K., Danjo, I., Aoki, N., & Nakamura, Y. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001544 · Cited by 93 · cited 6×
“Of note, MEDEP-BRC5, one of the MEDEP cell lines we previously reported [8], has maintained the ability for high rates of production of enucleated RBCs in vitro even after continuous culture for nearly 2 years; in this cell line, more than 50% of the cells are enucleated RBCs after induction of differentiation in vitr…”
BackgroundMethodSelf-citationDumitriu, B., Patrick, M. R., Petschek, J. P., Cherukuri, S., Klingmuller, U., Fox, P. L., & Lefebvre, V. (2006) · Blood · doi:10.1182/blood-2006-02-004184 · Cited by 85 · cited 1×
“This was also the case for c-MYB and SOX6, which are markers of definitive erythroid cells [22,23,24].”
ResultPrimitive erythropoiesis and megakaryopoiesis in the yolk sac are independent of c-myb
Tober, J., McGrath, K. E., & Palis, J. (2008) · Blood · doi:10.1182/blood-2007-11-124685 · Cited by 76 · cited 1×
“This was also the case for c-MYB and SOX6, which are markers of definitive erythroid cells [22,23,24].”
ResultOxygen Affinity of Hemoglobin Regulates O2Consumption, Metabolism, and Physical Activity
Shirasawa, T., Izumizaki, M., Suzuki, Y., Ishihara, A., Shimizu, T., Tamaki, M., Huang, F., Koizumi, K.-I., Iwase, M., Sakai, H., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211110200 · Cited by 70 · cited 1×
“We used a Hemox-Analyzer to measure the oxygen binding and dissociation abilities of the hemoglobin produced in mature cells derived from the HiDEP and HUDEP cells [20,21].”
MethodErythroid cells in vitro: from developmental biology to blood transfusion products
Migliaccio, A. R., Whitsett, C., & Migliaccio, G. (2009) · Current Opinion in Hematology · doi:10.1097/moh.0b013e32832bcaa2 · Cited by 60 · cited 1×
“in vitro [1,2,3] from hematopoietic stem/progenitor cells [4,5], embryonic stem (ES) cells [6], or induced pluripotent stem (iPS) cells [7].”
BackgroundSakai, H., Cabrales, P., Tsai, A. G., Tsuchida, E., & Intaglietta, M. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01184.2004 · Cited by 32 · cited 1×
“We used a Hemox-Analyzer to measure the oxygen binding and dissociation abilities of the hemoglobin produced in mature cells derived from the HiDEP and HUDEP cells [20,21].”
MethodKurita, R., Sasaki, E., Yokoo, T., Hiroyama, T., Takasugi, K., Imoto, H., Izawa, K., Yan, D., Hashiguchi, T., Soda, Y., et al. (2006) · Stem Cells · doi:10.1634/stemcells.2005-0499 · Cited by 31 · cited 2×
“Immunostaining with GPA antibody was performed as reported previously [12].”
BackgroundMethodSelf-citationEstablishment of induced pluripotent stem cells from human neonatal tissues
Fujioka, T., SHIMIZU, N., YOSHINO, K., Miyoshi, H., & Nakamura, Y. (2010) · Human Cell · doi:10.1111/j.1749-0774.2010.00091.x · Cited by 30 · cited 1×
“Therefore, we forced expression of TAL1 in human iPS cell lines (HiPS) [16] and established sub-lines, HiPS-TAL1.”
MethodSelf-citationStem Cells—A Source of Adult Red Blood Cells for Transfusion Purposes: Present and Future
Douay, L., Lapillonne, H., & Turhan, A. G. (2009) · Critical Care Clinics · doi:10.1016/j.ccc.2008.12.008 · Cited by 29 · cited 1×
“in vitro [1,2,3] from hematopoietic stem/progenitor cells [4,5], embryonic stem (ES) cells [6], or induced pluripotent stem (iPS) cells [7].”
BackgroundEstablishment of an erythroid cell line from primary CD36+ erythroid progenitor cells
Wong, S. C., Keyvanfar, K., Wan, Z., Kajigaya, S., Young, N. S., & Zhi, N. (2010) · Experimental Hematology · doi:10.1016/j.exphem.2010.07.012 · Cited by 22 · cited 2×
“Immortalized erythroid progenitor cell lines can be established by transformation of erythroid progenitor cells with the HPV16derived proteins HPV16-E6/E7 [17].”
BackgroundAnstee, D. J. (2010) · Transfusion Clinique et Biologique · doi:10.1016/j.tracli.2010.05.005 · Cited by 22 · cited 1×
“in vitro [1,2,3] from hematopoietic stem/progenitor cells [4,5], embryonic stem (ES) cells [6], or induced pluripotent stem (iPS) cells [7].”
BackgroundPlasticity of Cells andEx VivoProduction of Red Blood Cells
Hiroyama, T., Miharada, K., Kurita, R., & Nakamura, Y. (2011) · Stem Cells International · doi:10.4061/2011/195780 · Cited by 14 · cited 1×
“Of note, MEDEP-BRC5, one of the MEDEP cell lines we previously reported [8], has maintained the ability for high rates of production of enucleated RBCs in vitro even after continuous culture for nearly 2 years; in this cell line, more than 50% of the cells are enucleated RBCs after induction of differentiation in vitr…”
BackgroundSelf-citationConstruction of a high-performance human fetal liver-derived lentiviral cDNA library
Kurita, R., Oikawa, T., Okada, M., Yokoo, T., Kurihara, Y., Honda, Y., Kageyama, R., Suehiro, Y., Okazaki, T., Iga, M., et al. (2008) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-008-9891-5 · Cited by 8 · cited 1×
“The vesicular stomatitis virus G glycoprotein (VSV-G)-pseudotyped lentiviral vector preparation was performed as described previously [10] with the exception that Fugene HD (Roche, Mannheim, Germany) was used for transfection instead of polyethyleneimine.”
MethodSelf-citation
Cited by
BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis
Canver, M. C., Smith, E. C., Sher, F., Pinello, L., Sanjana, N. E., Shalem, O., Chen, D. D., Schupp, P. G., Vinjamur, D. S., Garcia, S. P., et al. (2015) · Nature · doi:10.1038/nature15521 · Cited by 886
Self-citationDirect promoter repression by BCL11A controls the fetal to adult hemoglobin switch
Liu, N., Hargreaves, V. V., Zhu, Q., Kurland, J. V., Hong, J., Kim, W., Sher, F., Macias-Trevino, C., Rogers, J. M., Kurita, R., et al. (2018) · Cell · doi:10.1016/j.cell.2018.03.016 · Cited by 478
“BCL11A CUT&RUN was performed in expansion-phase HUDEP-2 cells (Kurita et al., 2013) and primary human stem/progenitor CD34 cells (Xu et al.”
BackgroundMethodInfluentialSelf-citationExploring genetic interaction manifolds constructed from rich single-cell phenotypes
Norman, T. M., Horlbeck, M. A., Replogle, J. M., Ge, A. Y., Xu, A., Jost, M., Gilbert, L. A., & Weissman, J. S. (2019) · Science · doi:10.1126/science.aax4438 · Cited by 392
Transcription factors LRF and BCL11A independently repress expression of fetal hemoglobin
Masuda, T., Wang, X., Maeda, M., Canver, M. C., Sher, F., Funnell, A. P. W., Fisher, C., Suciu, M., Martyn, G. E., Norton, L. J., et al. (2016) · Science · doi:10.1126/science.aad3312 · Cited by 373
Self-citationTraxler, E. A., Yao, Y., Wang, Y.-D., Woodard, K. J., Kurita, R., Nakamura, Y., Hughes, J. R., Hardison, R. C., Blobel, G. A., Li, C., et al. (2016) · Nature Medicine · doi:10.1038/nm.4170 · Cited by 366
Self-citation
Metadata
- Authors
- Kurita, R., Suda, N., Sudo, K., Miharada, K., Hiroyama, T., Miyoshi, H., Tani, K., & Nakamura, Y.
- Affiliations
- RIKEN BioResource Research Center (JP)
- Kyushu University (JP)
- Corresponding author
- Nakamura, Yukio
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-03-22
- Volume
- 8
- Issue
- 3
- Pages
- e59890
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3606290
- OpenAlex
- W1974742081
- Cited by
- 418
- References
- 28
- Citations by year
- 2026: 38 · 2025: 43 · 2024: 34 · 2023: 36 · 2022: 35 · 2021: 48 · 2020: 45 · 2019: 31 · 2018: 32 · 2017: 24 · 2016: 25 · 2015: 10 · 2014: 8 · 2013: 8
- FWCI
- 12.19
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Ministry of Education, Culture, Sports, Science and Technology
- RIKEN
- RIKEN Brain Science Institute
- Topics
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Health Sciences › Medicine › Hematology › Blood transfusion and management
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Keywords
- erythroid progenitor cells, immortalized cell lines, in vitro erythropoiesis, blood transfusion, erythroid differentiation
- MeSH terms
- Cell Nucleus, Erythrocytes, Erythropoiesis, Humans, Erythroid Precursor Cells, Erythrocyte Transfusion
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.